In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IntraBiotics Pharmaceuticals brings in $18.4mm

Executive Summary

Infectious disease drug company IntraBiotics Pharmaceuticals expects to net about $18.4mm with a private placement of approximately 1.8mm common shares at $10.85 (a 9% discount to market) to a group of current and new institutional investors. Buyers will also receive warrants to purchase 355k shares at the same price.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies